Similar to our study, SpiA demonstrated anti-proliferative activity against several carcinoma cells and induced autophagy and apoptosis by regulating the PI3K/Akt/mTOR, MAPK, and p53 signaling pathways in human carcinoma HCT116 cells [29]. The gene discussed is TP53; the disease is carcinoma.